01.08.2020 | Case report
Blinatumomab
Cytokine release syndrome and neurotoxicity following off-label use: 4 case reports
Erschienen in: Reactions Weekly | Ausgabe 1/2020
Einloggen, um Zugang zu erhaltenExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event